When people ask about the success rate of Spravato® treatment, they usually want to know one thing: what are the chances you will feel meaningfully better? In research and clinical practice, “success” is typically measured as response (a significant drop in depression symptoms) and remission (symptoms improving to a low level, sometimes described as near-resolution). Your clinician may also track practical outcomes like sleep, energy, and ability to function day to day.
What this guide covers:
Across clinical trials, many patients experience meaningful symptom improvement with Spravato® treatment, including people who have not responded well to standard antidepressants. Results vary based on the population studied, the severity and duration of symptoms, and how “success” is defined, but research commonly reports that a substantial portion of patients achieve a meaningful reduction in symptoms, with a smaller portion reaching remission.
A realistic way to frame this is: Spravato® treatment can meaningfully improve symptoms for many adults with treatment-resistant depression, but it is not a guaranteed outcome for everyone. You and your clinician will typically review early symptom changes over the first several weeks, because early improvement can help guide whether it is worth continuing, adjusting, or combining strategies.
Your personal “success rate” depends on more than the medication itself. Clinicians often see better Spravato® outcomes when treatment is delivered within a clear, integrated plan. Factors that can influence results include:
It also helps when your sessions feel structured and supportive. Since Spravato® requires monitoring after each dose, a calm environment and a team that guides you through expectations can make it easier to stay consistent.
So, what is the success rate of Spravato® treatment? The answer is that it depends on a variety of factors. If you want a personalized estimate based on your symptoms and treatment history, request an appointment to review whether Spravato® treatment fits your next step.